Mitigating RNA Toxicity in Myotonic Dystrophy using Small Molecules

This review, one in a series on myotonic dystrophy (DM), is focused on the development and potential use of small molecules as therapeutics for DM. The complex mechanisms and pathogenesis of DM are covered in the associated reviews. Here, we examine the various small molecule approaches taken to tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Kaalak, Jenquin, Jana R., Cleary, John D., Berglund, J. Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720693/
https://www.ncbi.nlm.nih.gov/pubmed/31426500
http://dx.doi.org/10.3390/ijms20164017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720693/
https://www.ncbi.nlm.nih.gov/pubmed/31426500
http://dx.doi.org/10.3390/ijms20164017

Ejemplares similares